GlassScriptPhysician profile
Michael F Wesson
NPI 1760437321
$684.96
in general payments reported to CMS, 2019-2025
10 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $23.14 · 2021: $159 · 2022: $20.00 · 2023: $17.45 · 2024: $119 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $274.85 | 2019-2025 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning, Brainlab, INC. |
| Janssen Biotech, INC. | $174.29 | 2019-2022 | |
| Gt Medical Technologies, INC | $61.76 | 2025 | Gammatile |
| Sumitomo Pharma America, INC. | $37.78 | 2025 | Orgovyx |
| Boston Scientific Corporation | $32.38 | 2025 | Spaceoar System |
| Bioprotect Medical, INC. | $32.31 | 2025 | Bioprotect Balloon Implant System |
| Novocure INC. | $27.42 | 2024 | Optune |
| Palette Life Sciences, INC. | $17.45 | 2023 | |
| Siemens Medical Solutions USA, INC. | $14.22 | 2024 | Varian Treatment |
| Fortovia Therapeutics, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wesson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.